Skip to main content
Top
Published in: Pituitary 6/2018

Open Access 01-12-2018

Work disability and its determinants in patients with pituitary tumor-related disease

Authors: Daniel J. Lobatto, Anath N. V. Steffens, Amir H. Zamanipoor Najafabadi, Cornelie D. Andela, Alberto M. Pereira, Wilbert B. van den Hout, Wilco C. Peul, Thea P. M. Vliet Vlieland, Nienke R. Biermasz, Wouter R. van Furth

Published in: Pituitary | Issue 6/2018

Login to get access

Abstract

Introduction

Pituitary tumors may have a considerable impact on patients’ functional status, including paid employment, yet research in this area is sparse.

Objective

To describe work disability and its determinants in patients treated for a pituitary tumor.

Methods

Cross-sectional study including patients treated for a pituitary tumor in the working age (18–65 years), who completed five validated questionnaires assessing work disability [Short Form-Health and Labour Questionnaire, Work Role Functioning Questionnaire 2.0 (WRFQ)], health-related quality of life (HRQoL) and utility (Short Form-36, EuroQoL) and disease burden (Leiden Bother and Needs Questionnaire-Pituitary). Additional data were extracted from the medical records (age, gender, tumor type, treatment, date of diagnosis) and self-reports (marital status, education, endocrine status). Associations of disease-specific and sociodemographic characteristics, HRQoL, and disease burden with (not) having a paid job were examined through multivariate logistic regression.

Results

We included 241 patients (61% female, median age 53 years, median time since diagnosis 11 years), of whom 68 (28%) were without a paid job. Patients who had acromegaly, Cushing’s disease, (pan)hypopituitarism, radiotherapy, were single, less educated, lower HRQoL, and increased disease burden were more often without a paid job (p < 0.05). Among those with paid jobs, 41% reported health-related absenteeism in the previous year. The three work incapacitating problems reported by the largest proportion of patients were within the mental and social domain (WRFQ).

Conclusion

Work disability among patients treated for a pituitary tumor is substantial. As impact on social functioning is high, it is strongly advised to incorporate work disability during clinical guidance of patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP et al (2008) Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol 69(5):775–784CrossRef van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP et al (2008) Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol 69(5):775–784CrossRef
2.
go back to reference Andela CD, Scharloo M, Pereira AM, Kaptein A, Biermasz NR (2015) Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 18:752–776CrossRef Andela CD, Scharloo M, Pereira AM, Kaptein A, Biermasz NR (2015) Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 18:752–776CrossRef
3.
go back to reference Andela CD, Lobatto DJ, Pereira AM, van Furth WR, Biermasz NR (2018) How non-functioning pituitary adenomas can affect health-related quality of life: a conceptual model and literature review. Pituitary 21(2):208–216CrossRef Andela CD, Lobatto DJ, Pereira AM, van Furth WR, Biermasz NR (2018) How non-functioning pituitary adenomas can affect health-related quality of life: a conceptual model and literature review. Pituitary 21(2):208–216CrossRef
4.
go back to reference Andela CD, Niemeijer ND, Scharloo M, Tiemensma J, Kanagasabapathy S, Pereira AM et al (2015) Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL. Pituitary 18(1):86–100CrossRef Andela CD, Niemeijer ND, Scharloo M, Tiemensma J, Kanagasabapathy S, Pereira AM et al (2015) Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL. Pituitary 18(1):86–100CrossRef
5.
go back to reference Hakkaart-van Roijen L, Beckers A, Stevenaert A, Rutten FF (1998) The burden of illness of hypopituitary adults with growth hormone deficiency. Pharmacoeconomics 14(4):395–403CrossRef Hakkaart-van Roijen L, Beckers A, Stevenaert A, Rutten FF (1998) The burden of illness of hypopituitary adults with growth hormone deficiency. Pharmacoeconomics 14(4):395–403CrossRef
6.
go back to reference Jahangiri A, Clark AJ, Han SJ, Kunwar S, Blevins LS, Aghi MK (2013) Socioeconomic factors associated with pituitary apoplexy. J Neurosurg 119(6):1432–1436CrossRef Jahangiri A, Clark AJ, Han SJ, Kunwar S, Blevins LS, Aghi MK (2013) Socioeconomic factors associated with pituitary apoplexy. J Neurosurg 119(6):1432–1436CrossRef
7.
go back to reference Pikkarainen L, Sane T, Reunanen A (1999) The survival and well-being of patients treated for Cushing’s syndrome. J Intern Med 245(5):463–468CrossRef Pikkarainen L, Sane T, Reunanen A (1999) The survival and well-being of patients treated for Cushing’s syndrome. J Intern Med 245(5):463–468CrossRef
8.
go back to reference Wagenmakers MAEM, Netea-Maier RT, Prins JB, Dekkers T, den Heijer M, Hermus ARMM (2012) Impaired quality of life in patients in long-term remission of Cushing’s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism? Eur J Endocrinol 167(5):687–695CrossRef Wagenmakers MAEM, Netea-Maier RT, Prins JB, Dekkers T, den Heijer M, Hermus ARMM (2012) Impaired quality of life in patients in long-term remission of Cushing’s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism? Eur J Endocrinol 167(5):687–695CrossRef
9.
go back to reference Brod M, Pohlman B, Højbjerre L, Adalsteinsson JE, Rasmussen MH (2014) Impact of adult growth hormone deficiency on daily functioning and well-being. BMC Res Notes 7:813CrossRef Brod M, Pohlman B, Højbjerre L, Adalsteinsson JE, Rasmussen MH (2014) Impact of adult growth hormone deficiency on daily functioning and well-being. BMC Res Notes 7:813CrossRef
10.
go back to reference Jonsson B, Nilsson B (2000) The impact of pituitary adenoma on morbidity. Increased sick leave and disability retirement in a cross-sectional analysis of Swedish national data. Pharmacoeconomics 18(1):73–81CrossRef Jonsson B, Nilsson B (2000) The impact of pituitary adenoma on morbidity. Increased sick leave and disability retirement in a cross-sectional analysis of Swedish national data. Pharmacoeconomics 18(1):73–81CrossRef
11.
go back to reference Ehrnborg C, Hakkaart-Van Roijen L, Jonsson B, Rutten FF, Bengtsson BA, Rosén T (2000) Cost of illness in adult patients with hypopituitarism. Pharmacoeconomics 17(6):621–628CrossRef Ehrnborg C, Hakkaart-Van Roijen L, Jonsson B, Rutten FF, Bengtsson BA, Rosén T (2000) Cost of illness in adult patients with hypopituitarism. Pharmacoeconomics 17(6):621–628CrossRef
12.
go back to reference Saller B, Mattsson AF, Kann PH, Koppeschaar HP, Svensson J, Pompen M et al (2006) Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults–comparison between Sweden, The Netherlands and Germany. Eur J Endocrinol 154(6):843–850CrossRef Saller B, Mattsson AF, Kann PH, Koppeschaar HP, Svensson J, Pompen M et al (2006) Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults–comparison between Sweden, The Netherlands and Germany. Eur J Endocrinol 154(6):843–850CrossRef
13.
go back to reference Weigold A, Weigold IK, Russell EJ (2013) Examination of the equivalence of self-report survey-based paper-and-pencil and internet data collection methods. Psychol Methods 18(1):53–70CrossRef Weigold A, Weigold IK, Russell EJ (2013) Examination of the equivalence of self-report survey-based paper-and-pencil and internet data collection methods. Psychol Methods 18(1):53–70CrossRef
14.
go back to reference Dekkers OM, Biermasz NR, Pereira AM, Roelfsema F, van Aken MO, Voormolen JHC et al (2007) Mortality in patients treated for Cushing’s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 92(3):976–981CrossRef Dekkers OM, Biermasz NR, Pereira AM, Roelfsema F, van Aken MO, Voormolen JHC et al (2007) Mortality in patients treated for Cushing’s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 92(3):976–981CrossRef
15.
go back to reference Dekkers OM, Hammer S, de Keizer RJW, Roelfsema F, Schutte PJ, Smit JWA et al (2007) The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol 156(2):217–224CrossRef Dekkers OM, Hammer S, de Keizer RJW, Roelfsema F, Schutte PJ, Smit JWA et al (2007) The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol 156(2):217–224CrossRef
16.
go back to reference Biermasz NR, Dekkers OM, Voormolen J, de Keizer RJW, Neelis KJ, Wiggers-de Bruïne FT et al (2008) Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center. Ned Tijdschr Geneeskd 152(47):2565–2570PubMed Biermasz NR, Dekkers OM, Voormolen J, de Keizer RJW, Neelis KJ, Wiggers-de Bruïne FT et al (2008) Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center. Ned Tijdschr Geneeskd 152(47):2565–2570PubMed
17.
go back to reference Standaard Onderwijsindeling 2016 - Editie 2017/’18, Centraal Bureau voor de Statistiek, Den Haag/Heerlen 2018, The Netherlands Standaard Onderwijsindeling 2016 - Editie 2017/’18, Centraal Bureau voor de Statistiek, Den Haag/Heerlen 2018, The Netherlands
18.
go back to reference UNESCO Institute for Statistics (2014) International standard classification of education, ISCED-F 2013. Montreal, Canada UNESCO Institute for Statistics (2014) International standard classification of education, ISCED-F 2013. Montreal, Canada
19.
go back to reference van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF (1996) Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care 12(3):405–415CrossRef van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF (1996) Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care 12(3):405–415CrossRef
20.
go back to reference Abma FI, van der Klink JJL, Bültmann U (2013) The work role functioning Questionnaire 2.0 (Dutch Version): examination of its reliability, validity and responsiveness in the general working population. J Occup Rehabil 23(1):135–147CrossRef Abma FI, van der Klink JJL, Bültmann U (2013) The work role functioning Questionnaire 2.0 (Dutch Version): examination of its reliability, validity and responsiveness in the general working population. J Occup Rehabil 23(1):135–147CrossRef
21.
go back to reference Ware JE, Sherbourne CD (1992) The MOS 36-ltem short-form health survey (SF-36). Med Care 30(6):473–483CrossRef Ware JE, Sherbourne CD (1992) The MOS 36-ltem short-form health survey (SF-36). Med Care 30(6):473–483CrossRef
22.
go back to reference EuroQoL Group (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208CrossRef EuroQoL Group (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208CrossRef
23.
go back to reference Andela CD, Scharloo M, Ramondt S, Tiemensma J, Husson O, Llahana S et al (2016) The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-Pituitary. Pituitary 19(3):293–302CrossRef Andela CD, Scharloo M, Ramondt S, Tiemensma J, Husson O, Llahana S et al (2016) The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-Pituitary. Pituitary 19(3):293–302CrossRef
24.
go back to reference Shrier I, Platt RW (2008) Reducing bias through directed acyclic graphs. BMC Med Res Methodol 8(1):70CrossRef Shrier I, Platt RW (2008) Reducing bias through directed acyclic graphs. BMC Med Res Methodol 8(1):70CrossRef
26.
go back to reference Jahangiri A, Lamborn KR, Blevins L, Kunwar S, Aghi MK (2012) Factors associated with delay to pituitary adenoma diagnosis in patients with visual loss. J Neurosurg 116(2):283–289CrossRef Jahangiri A, Lamborn KR, Blevins L, Kunwar S, Aghi MK (2012) Factors associated with delay to pituitary adenoma diagnosis in patients with visual loss. J Neurosurg 116(2):283–289CrossRef
27.
go back to reference Santos A, Resmini E, Martínez MA, Marti C, Ybarra J, Webb SM (2009) Improving quality of life in patients with pituitary tumours. Curr Opin Endocrinol Diabetes Obes 16(4):299–303CrossRef Santos A, Resmini E, Martínez MA, Marti C, Ybarra J, Webb SM (2009) Improving quality of life in patients with pituitary tumours. Curr Opin Endocrinol Diabetes Obes 16(4):299–303CrossRef
28.
go back to reference Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A et al (2008) Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire. Eur J Endocrinol 158(5):623–630CrossRef Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A et al (2008) Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire. Eur J Endocrinol 158(5):623–630CrossRef
29.
go back to reference van der Klaauw AA, Biermasz NR, Hoftijzer HC, Pereira AM, Romijn JA (2008) Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. Clin Endocrinol 69(1):123–128CrossRef van der Klaauw AA, Biermasz NR, Hoftijzer HC, Pereira AM, Romijn JA (2008) Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. Clin Endocrinol 69(1):123–128CrossRef
30.
go back to reference van Muijen P, Weevers NLEC, Snels IAK, Duijts SFA, Bruinvels DJ, Schellart AJM et al (2013) Predictors of return to work and employment in cancer survivors: a systematic review. Eur J Cancer Care 22(2):144–160CrossRef van Muijen P, Weevers NLEC, Snels IAK, Duijts SFA, Bruinvels DJ, Schellart AJM et al (2013) Predictors of return to work and employment in cancer survivors: a systematic review. Eur J Cancer Care 22(2):144–160CrossRef
31.
go back to reference Donker-Cools BHPM, Wind H, Frings-Dresen MHW (2016) Prognostic factors of return to work after traumatic or non-traumatic acquired brain injury. Disabil Rehabil 38(8):733–741CrossRef Donker-Cools BHPM, Wind H, Frings-Dresen MHW (2016) Prognostic factors of return to work after traumatic or non-traumatic acquired brain injury. Disabil Rehabil 38(8):733–741CrossRef
33.
go back to reference Asa SL, Kucharczyk W, Ezzat S (2017) Pituitary acromegaly: not one disease. Endocr Relat Cancer 24(3):C1–C4CrossRef Asa SL, Kucharczyk W, Ezzat S (2017) Pituitary acromegaly: not one disease. Endocr Relat Cancer 24(3):C1–C4CrossRef
34.
go back to reference Geraedts VJ, Andela CD, Stalla GK, Pereira AM, van Furth WR, Sievers C et al (2017) Predictors of quality of life in acromegaly: no consensus on biochemical parameters. Front Endocrinol 8:40CrossRef Geraedts VJ, Andela CD, Stalla GK, Pereira AM, van Furth WR, Sievers C et al (2017) Predictors of quality of life in acromegaly: no consensus on biochemical parameters. Front Endocrinol 8:40CrossRef
35.
go back to reference Trepp R, Everts R, Stettler C, Fischli S, Allemann S, Webb SM et al (2005) Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the acromegaly quality of life questionnaire (AcroQoL). Clin Endocrinol 63(1):103–110CrossRef Trepp R, Everts R, Stettler C, Fischli S, Allemann S, Webb SM et al (2005) Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the acromegaly quality of life questionnaire (AcroQoL). Clin Endocrinol 63(1):103–110CrossRef
36.
go back to reference Porter ME (2014) What is value in health care? N Engl J Med 363(26):2477–2481CrossRef Porter ME (2014) What is value in health care? N Engl J Med 363(26):2477–2481CrossRef
37.
go back to reference Abma FI, Bültmann U, Amick Iii BC, Arends I, Dorland HF et al (2018) The work role functioning questionnaire v2.0 showed consistent factor structure across six working samples. J Occup Rehabil 28(3):465–474CrossRef Abma FI, Bültmann U, Amick Iii BC, Arends I, Dorland HF et al (2018) The work role functioning questionnaire v2.0 showed consistent factor structure across six working samples. J Occup Rehabil 28(3):465–474CrossRef
38.
go back to reference Mehnert A (2011) Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol 77(2):109–130CrossRef Mehnert A (2011) Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol 77(2):109–130CrossRef
39.
go back to reference van Vilsteren M, Boot CRL, Knol DL, van Schaardenburg D, Voskuyl AE, Steenbeek R et al (2015) Productivity at work and quality of life in patients with rheumatoid arthritis. BMC Musculoskelet Disord 16:107CrossRef van Vilsteren M, Boot CRL, Knol DL, van Schaardenburg D, Voskuyl AE, Steenbeek R et al (2015) Productivity at work and quality of life in patients with rheumatoid arthritis. BMC Musculoskelet Disord 16:107CrossRef
40.
go back to reference van Lier LI, Bosmans JE, van Hout HPJ, Mokkink LB, van den Hout WB, de Wit GA et al (2018) Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study. Eur J Heal Econ 19(7):993–1008CrossRef van Lier LI, Bosmans JE, van Hout HPJ, Mokkink LB, van den Hout WB, de Wit GA et al (2018) Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study. Eur J Heal Econ 19(7):993–1008CrossRef
41.
go back to reference Verstappen SMM, Bijlsma JWJ, Verkleij H, Buskens E, Blaauw AAM, ter Borg EJ et al (2004) Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Care Res 51(3):488–497CrossRef Verstappen SMM, Bijlsma JWJ, Verkleij H, Buskens E, Blaauw AAM, ter Borg EJ et al (2004) Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Care Res 51(3):488–497CrossRef
Metadata
Title
Work disability and its determinants in patients with pituitary tumor-related disease
Authors
Daniel J. Lobatto
Anath N. V. Steffens
Amir H. Zamanipoor Najafabadi
Cornelie D. Andela
Alberto M. Pereira
Wilbert B. van den Hout
Wilco C. Peul
Thea P. M. Vliet Vlieland
Nienke R. Biermasz
Wouter R. van Furth
Publication date
01-12-2018
Publisher
Springer US
Published in
Pituitary / Issue 6/2018
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-018-0913-3

Other articles of this Issue 6/2018

Pituitary 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.